Cite
MLA Citation
Kari E. Sufficool et al.. “Histopathologic characteristics of therapy‐associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma.” Journal of cutaneous pathology, vol. 41, n.d., pp. 568–575. http://access.bl.uk/ark:/81055/vdc_100082988094.0x000001